Update on the FDA's Veterinary Guidance for Industry 256
Industry Update Regarding the Below Previous Blog Post (9/12/2022) Many compounders and compounding advocacy groups have expressed concern regarding the upcoming FDA guidance on veterinary compounding. On Friday, September 9th the FDA granted a six-month extension (until April 2023) on enforcement of Veterinary Guidance for Industry (“GFI”) 256. Check out our below blog post reviewing key points from GFI 256 as well as how you can nominate substances to the FDA’s List of Bulk Drug Substances for Compounding Office Stock Drugs for Use in Nonfood-Producing Animals. Thank you to our industry partners, the Alliance for Pharmacy Compounding, the American College of Veterinary Pharmacists, the American Pharmacists Association, the National Community Pharmacists Association, and the Society of Veterinary Hospital Pharmacists for the hard work to influence the extension to the enforcement date. GFI #256 – What You Need to Know About Animal Drug Compounding for Non-Food Producing Animals